IVD，许可申请和交换生态系统：医疗创新的新时代

IVD医疗控股先驱A'Newco+RWA'Web3交换生态系统，旨在彻底改变医疗资产流动性和价值转换。发现其Stablecoin许可申请的含义。

IVD, License Application, and the Exchange Ecosystem: A New Era for Medical Innovation

IVD，许可申请和交换生态系统：医疗创新的新时代

In the dynamic world of digital finance and medical breakthroughs, a groundbreaking initiative is taking shape. IVD Medical Holding is forging a path with its 'NewCo+RWA' Web3 exchange ecosystem, designed to transform how medical assets are valued and exchanged.

在数字金融和医疗突破的动态世界中，一项开创性的计划正在形成。 IVD医疗控股公司正在使用其“ Newco+RWA” Web3 Exchange生态系统开辟道路，旨在改变医疗资产的重视和交换方式。

IVD Medical Holding's Bold Move

IVD医疗控股的大胆举动

IVD Medical Holding (01931.HK) is strategically positioning itself to capitalize on the US 'Genius Act' with its IVDD stablecoin plan. This initiative aims to establish a novel global infrastructure for medical innovative drugs RWA (Real World Assets). Their approach centers on constructing a 'NewCo+RWA' Web3 exchange ecosystem (IVDNewCo Exchange), underpinned by the 'IVDDollar' (IVDD) stablecoin. This is all about digitally revolutionizing global medical innovation assets.

IVD医疗控股（01931.HK）从战略上定位了自己的IVDD Stablecoin计划，以利用美国的“天才法”。该计划旨在为医学创新药物RWA（现实世界资产）建立新的全球基础设施。他们的方法集中在构建“ newco+rwa” Web3交换生态系统（IVDNewco Exchange）的基础上，该生态系统（IVDDollar'（IVDD）（IVDD）StableCoin为基础。这全都是关于将全球医学创新资产革新的。

Strategic Opportunities Under Global Regulatory Resonance

全球监管共鸣的战略机会

With the US 'Genius Act' establishing stablecoins as 'digital dollars' and Hong Kong's Stablecoin Ordinance, IVD Medical is strategically aligned with global regulatory trends. By proactively pursuing a US stablecoin license through its US subsidiary, IVD GROUP INC., the company aims to be a frontrunner in compliant digital finance for medical innovation.

随着美国的“天才法案”将稳定的人建立为“数字美元”和香港的Stablecoin条例，IVD医学在战略上与全球监管趋势保持一致。通过通过其美国子公司IVD Group Inc.积极寻求美国稳定许可证，该公司的目标是成为合规数字融资医疗创新的领先者。

Technological Innovation: Reconstructing the Value Chain

技术创新：重建价值链

The IVDNewCo Exchange ecosystem's core breakthrough lies in integrating Web3 technology with medical innovative drug assets. By tokenizing innovative drug assets and establishing a compliance financial infrastructure, IVD Medical aims to improve financing efficiency and lower investor entry barriers. The idea is to convert innovative drug assets such as ADC drugs, bi-antibody therapy, and cell gene therapy in the clinical stage into tradable and divisible digital certificates to break through the liquidity bottleneck of traditional medical assets.

IVDNEWCO交换生态系统的核心突破在于将Web3技术与医学创新药物资产整合在一起。通过对创新的毒品资产进行统治并建立合规性基础设施，IVD Medical旨在提高融资效率并降低投资者进入障碍。这个想法是将临床阶段的ADC药物，双抗体疗法和细胞基因疗法等创新的药物资产转换为可贸易且可分割的数字证书，以破坏传统医疗资产的流动性瓶颈。

The Exchange Ecosystem: A Closer Look

交换生态系统：仔细观察

The IVDNewCo Exchange ecosystem represents a paradigm shift in medical finance. By enabling the monetization of clinical-stage assets, IVD Medical provides pharmaceutical companies with low-cost financing and investors with dynamic returns linked to drug development progress. This has the potential to reshape the value chain of innovative medical drugs.

IVDNEWCO交换生态系统代表了医疗金融的范式转变。通过实现临床资产的货币化，IVD Medical为制药公司提供低成本融资和投资者，并具有与药物开发进度有关的动态回报。这有可能重塑创新医学药物的价值链。

Industry Impact and Future Outlook

行业影响和未来前景

IVD Medical's strategic moves have garnered significant attention, reflected in its share price surge. As the company continues to deepen its compliance, technology, and ecological integration strategies, it aims to bridge traditional medical capital with digital financial innovation. They envision the IVDNewCo Exchange ecosystem as a value amplifier for global innovative medical drug assets, benefiting patients, pharmaceutical companies, and investors alike.

IVD Medical的战略举动引起了极大的关注，这反映在其股价上涨。随着公司继续加深其合规性，技术和生态整合策略，它旨在通过数字金融创新桥接传统的医疗资本。他们将IVDNEWCO交换生态系统视为全球创新医学药物资产的价值放大器，使患者，制药公司和投资者都受益。

Final Thoughts

最后的想法

So, will IVD Medical Holding’s ambitious plan to create a compliant and innovative exchange ecosystem for medical assets pay off? Only time will tell, but one thing's for sure: they're shaking things up in the world of medical finance. Keep an eye on this space – it’s gonna be interesting!

因此，IVD医疗控股公司的雄心勃勃的计划是否会为医疗资产创建合规，创新的交换生态系统吗？只有时间会说明，但可以肯定的是：他们在医疗金融领域摇晃了事情。密切关注这个空间 - 这将很有趣！